Literature DB >> 2154600

Structural organization of poliovirus RNA replication is mediated by viral proteins of the P2 genomic region.

K Bienz1, D Egger, M Troxler, L Pasamontes.   

Abstract

Transcriptionally active replication complexes bound to smooth membrane vesicles were isolated from poliovirus-infected cells. In electron microscopic, negatively stained preparations, the replication complex appeared as an irregularly shaped, oblong structure attached to several virus-induced vesicles of a rosettelike arrangement. Electron microscopic immunocytochemistry of such preparations demonstrated that the poliovirus replication complex contains the proteins coded by the P2 genomic region (P2 proteins) in a membrane-associated form. In addition, the P2 proteins are also associated with viral RNA, and they can be cross-linked to viral RNA by UV irradiation. Guanidine hydrochloride prevented the P2 proteins from becoming membrane bound but did not change their association with viral RNA. The findings allow the conclusion that the protein 2C or 2C-containing precursor(s) is responsible for the attachment of the viral RNA to the vesicular membrane and for the spatial organization of the replication complex necessary for its proper functioning in viral transcription. A model for the structure of the viral replication complex and for the function of the 2C-containing P2 protein(s) and the vesicular membranes is proposed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2154600      PMCID: PMC249229          DOI: 10.1128/JVI.64.3.1156-1163.1990

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

1.  The role of cytoplasmic membranes in poliovirus biosynthesis.

Authors:  L A Caliguiri; I Tamm
Journal:  Virology       Date:  1970-09       Impact factor: 3.616

2.  Dynamics of poliovirus-specific RNA synthesis and the effects of inhibitors of virus replication.

Authors:  J Noble; L Levintow
Journal:  Virology       Date:  1970-03       Impact factor: 3.616

3.  Soluble RNA polymerase complex from poliovirus-infected HeLa cells.

Authors:  E Ehrenfeld; J V Maizel; D F Summers
Journal:  Virology       Date:  1970-04       Impact factor: 3.616

4.  Virus replication, cytopathology, and lysosomal enzyme response of mitotic and interphase Hep-2 cells infected with poliovirus.

Authors:  K Bienz; D Egger; D A Wolff
Journal:  J Virol       Date:  1973-04       Impact factor: 5.103

5.  Action of guanidine on the replication of poliovirus RNA.

Authors:  L A Caliguiri; I Tamm
Journal:  Virology       Date:  1968-07       Impact factor: 3.616

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Specificity in the interaction of hnRNA and mRNA with proteins as revealed by in vivo cross linking.

Authors:  C A van Eekelen; T Riemen; W J van Venrooij
Journal:  FEBS Lett       Date:  1981-08-03       Impact factor: 4.124

8.  Comparison of replication complexes synthesizing poliovirus RNA.

Authors:  D Etchison; E Ehrenfeld
Journal:  Virology       Date:  1981-05       Impact factor: 3.616

9.  Association of the polioviral RNA polymerase complex with phospholipid membranes.

Authors:  B E Butterworth; E J Shimshick; F H Yin
Journal:  J Virol       Date:  1976-08       Impact factor: 5.103

10.  Membranous structures associated with translation and transcription of poliovirus RNA.

Authors:  L A Caliguiri; I Tamm
Journal:  Science       Date:  1969-11-14       Impact factor: 47.728

View more
  119 in total

1.  Markers for trans-Golgi membranes and the intermediate compartment localize to induced membranes with distinct replication functions in flavivirus-infected cells.

Authors:  J M Mackenzie; M K Jones; E G Westaway
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

2.  A cysteine-rich motif in poliovirus protein 2C(ATPase) is involved in RNA replication and binds zinc in vitro.

Authors:  T Pfister; K W Jones; E Wimmer
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

3.  Identification of an RNA hairpin in poliovirus RNA that serves as the primary template in the in vitro uridylylation of VPg.

Authors:  A V Paul; E Rieder; D W Kim; J H van Boom; E Wimmer
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

4.  Initiation of poliovirus negative-strand RNA synthesis requires precursor forms of p2 proteins.

Authors:  Christy Jurgens; James B Flanegan
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

5.  Recombination of poliovirus RNA proceeds in mixed replication complexes originating from distinct replication start sites.

Authors:  Denise Egger; Kurt Bienz
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

6.  Grapevine fanleaf virus replication occurs on endoplasmic reticulum-derived membranes.

Authors:  C Ritzenthaler; C Laporte; F Gaire; P Dunoyer; C Schmitt; S Duval; A Piéquet; A M Loudes; O Rohfritsch; C Stussi-Garaud; P Pfeiffer
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

7.  Isolation of enzymatically active replication complexes from feline calicivirus-infected cells.

Authors:  Kim Y Green; Aaron Mory; Mark H Fogg; Andrea Weisberg; Gaël Belliot; Mariam Wagner; Tanaji Mitra; Ellie Ehrenfeld; Craig E Cameron; Stanislav V Sosnovtsev
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

8.  Aichi virus leader protein is involved in viral RNA replication and encapsidation.

Authors:  Jun Sasaki; Shigeo Nagashima; Koki Taniguchi
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

9.  A new cis-acting element for RNA replication within the 5' noncoding region of poliovirus type 1 RNA.

Authors:  K Shiroki; T Ishii; T Aoki; M Kobashi; S Ohka; A Nomoto
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

10.  Poliovirus protein 3AB forms a complex with and stimulates the activity of the viral RNA polymerase, 3Dpol.

Authors:  S J Plotch; O Palant
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.